New injection aims to smooth away frown lines and Crow's feet

NCT ID NCT04821089

First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 26 times

Summary

This study tests a new medication called IPN10200 to improve the appearance of moderate to severe frown lines, forehead lines, and crow's feet in adults aged 18 to 65. Researchers will compare different doses of IPN10200 to a placebo and to an existing treatment (Dysport) to find the safest and most effective dose. The study involves up to 727 participants across multiple stages, with some receiving repeat treatments over several cycles.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE UPPER FACIAL LINES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aimed S.A.S

    Lyon, France

  • CRS Clinical Research Services Berlin GMBH

    Berlin, 13353, Germany

  • Clinique de Chirurgie Esthétique Iéna

    Paris, France

  • Dermatologische Gemeinschaftspraxis Blankenfelde-Mahlow

    Mahlow, Germany

  • Fachbereich Chemie Institut für Biologie und Molekularbiologie Studiengang Kosmetikwissenschaft

    Hamburg, Germany

  • Interdisciplinary Study Association

    Kassel, State of Berlin, Germany

  • Interdisciplinary Study Association

    Berlin, Germany

  • MEDITI - Clinique Del Mar

    Antibes, France

  • Privatpraxis Dr. Hilton & Partner

    Düsseldorf, Germany

  • ROSENPARK RESEARCH GmbH

    Darmstadt, Germany

Conditions

Explore the condition pages connected to this study.